Form 8-K - Current report:
SEC Accession No. 0001558370-25-009062
Filing Date
2025-07-02
Accepted
2025-07-02 16:15:19
Documents
13
Period of Report
2025-06-26
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K elev-20250626x8k.htm   iXBRL 8-K 40515
  Complete submission text file 0001558370-25-009062.txt   164734

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20250626.xsd EX-101.SCH 4020
3 EX-101.DEF elev-20250626_def.xml EX-101.DEF 2821
4 EX-101.LAB elev-20250626_lab.xml EX-101.LAB 17917
5 EX-101.PRE elev-20250626_pre.xml EX-101.PRE 11885
15 EXTRACTED XBRL INSTANCE DOCUMENT elev-20250626x8k_htm.xml XML 5048
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 251101198
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)